Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 69
- Adult-Use
US Cannabis Sales to Hit $32bn This Year as Industry Continues Record Growth
The US cannabis industry is experiencing rapid growth, with retail sales projected to exceed $32bn in 2024 and wholesale sales reaching nearly $12bn, according to a new study from Leaflink.
- Uncategorized
Trumps DEA Pick Becomes 2nd Nominee to Withdraw Nomination Abruptly
Chad Chronister, the Florida county sheriff chosen by President-elect Donald Trump to lead the US Drug Enforcement Administration, abruptly withdrew his nomination for the post Tuesday.
- CBD Market
UK CBD Industry Sees Light at the End of the Tunnel: First Authorised Products Expected by Spring 2025
In a long-awaited and major step forward for the UK’s CBD sector, the regulator has announced a new roadmap that could see the first products given official approval by Spring next year.
- Medical
Compliance Meets Compassion: How Releaf’s Training Standards Set the Benchmark for Medical Cannabis in the UK
The medical cannabis sector in the UK is navigating a dual imperative: ensuring rigorous compliance with regulatory standards while delivering compassionate care to patients in need. For UK medical cannabis clinic Releaf, these two objectives are not only complementary but also foundational to its operations.
- Uncategorized
DEA Cannabis Rescheduling Hearing Takes Landmark First Step
The first step in the US’s landmark efforts to reschedule cannabis officially took place yesterday, setting the stage for what is set to be a lively and heated process.
- Press releases
Cannavigia to Expand US Operations as Medical Cannabis Rescheduling Remains a Focus
CANNAVIGIA (by Vigia AG), a global pioneer in cannabis compliance software and consulting, is expanding its presence in the U.S. market, building on recent regulatory developments related to the potential rescheduling of medical cannabis to Schedule III.
- Uncategorized
US Farm Bill Still Contains ‘Concerning Provisions’ For Hemp Businesses, Despite Efforts to Balance Draconian Measures
The new draft of the Senate’s US Farm Bill contains ‘concerning provisions’ around hemp, according to a leading lobby group.
- Uncategorized
Trump’s Cabinet Picks Leave Cannabis Reform in Limbo: A Mixed Bag of Allies and Opponents
Following the short-lived candidacy of Matt Gaetz for US Attorney General in President elect Donald Trumps new cabinet, the outlooks for cannabis reform under the incoming government is now looking much more complex.
- Uncategorized
Florida’s Medical Cannabis Industry to Nearly Double as First Licenses Issued in 5 Years
Florida’s medical cannabis industry is set to almost double, dismantling the monopoly 28 companies have held since 2017 in one of the US’s largest markets.
- Uncategorized
Motion to Remove DEA as Proponent of Cannabis Rescheduling Hearing Dismissed by Judge
As the DEA releases new details about the highly anticipated preliminary rescheduling hearing next week, efforts to remove the DEA as a ‘proponent’ of rescheduling have been dismissed by a judge.
- CBD Market
Ananda Aiming to ‘Meet Regulators at Their Point of Need’ As it Secures More Major UK Clinical Cannabis Trials
UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds.
- Uncategorized
Nebraska Medical Cannabis Initiatives Clear Hurdle as Judge Upholds Petition Validity
Nebraska’s dual medical cannabis bills, which were passed earlier this month as part of the election, are now set to go ahead after a lawsuit was dismissed by a county judge.
